Trial
NCT00734851
Multimodality Phase II Study in Prostate Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Duke University
Collaborators
Pfizer; Sanofi
Condition
Prostate Cancer
Intervention
Docetaxel
Why stopped
Dose Limiting Toxicities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-23